For influenza, the combination of NA inhibitors with adamantanes, favipiravir, or ribavirin was already successfully tested in cell culture and showed increased efficacy and prolonged survival of infected mice compared to the monotherapy [176,177,178,179,180]. The gene discussed is XK; the disease is influenza.